This inventor holds 1 USPTO granted patent. Top assignees: Ardan Pharma S.A.S., Institut Pasteur De Montevideo, Universidad De La Republica Oriental Del Uruguay. Active years: 2026.
Company Filing History:
1 out of 1 
1 out of 8 
1 out of 1 Years Active: 2026
Title: Analia Castro: Innovator in Anti-Tumoral Treatments
Introduction
Analia Castro is a notable inventor based in Montevideo, Uruguay. She has made significant contributions to the field of medical science, particularly in the development of anti-tumoral therapies. Her innovative work focuses on improving the efficacy of treatments for neoplastic pathologies.
Latest Patents
Analia Castro holds a patent titled "Means and methods for improving anti-tumoral efficacy of transmembrane channel protein blockers." This invention is related to an anti-tumoral composition designed for the treatment of malignant neoplastic pathologies, including eg7 thymic lymphoma. The composition comprises a TMEM176A/B inhibitor formulated in nanoparticles. Additionally, her invention includes a method for treating these malignant conditions by administering the TMEM176A/B inhibitor in nanoparticle form.
Career Highlights
Throughout her career, Analia has worked with various organizations, including Ardan Pharma S.A.S. and Universidad De La Republica Oriental Del Uruguay. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Analia has collaborated with notable colleagues such as Marcelo Rafael Hill Mongabure and Mercedes Segovia. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Analia Castro's work in developing anti-tumoral treatments showcases her dedication to advancing medical science. Her innovative approaches and collaborations highlight her significant role in the fight against cancer.